Literature DB >> 28342866

The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.

Sungryul Yu1, Taemook Kim2, Kyung Hyun Yoo3, Keunsoo Kang4.   

Abstract

Cell lines are often used as in vitro tools to mimic certain types of in vivo system; several cell lines, including MCF-7 and T47D, have been widely used in breast cancer studies without investigating the cell lines' characteristics. In this study, we compared the genome-wide binding profiles of ERα, PR, and P300, and the gene expression changes between MCF-7 and T47D cell lines that represent the luminal A subtype of breast cancer. Surprisingly, several thousand genes were differentially expressed under estrogenic condition. In addition, ERα, PR, and P300 binding to regulatory elements showed distinct genomic landscapes between MCF-7 and T47D cell lines in the same hormonal states. In particular, the T47D cell line was markedly susceptible to progesterone, whereas the MCF-7 cell line did not respond to progesterone in the presence of estrogen. Consistently, changes in the expression level of the PR-target gene, STAT5A, were only observed in the T47D cell line, not the MCF-7 cell line, when treated with progesterone. Overall, the results highlight the importance of selecting appropriate cell lines for breast cancer studies and suggest that T47D cell lines can be an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ERα; Estrogen receptor; MCF-7; PR; Progesterone receptor; T47D

Mesh:

Substances:

Year:  2017        PMID: 28342866     DOI: 10.1016/j.bbrc.2017.03.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Cancer biomarker profiling using nanozyme containing iron oxide loaded with gold particles.

Authors:  Victor Akpe; Muhammad J A Shiddiky; Tak H Kim; Christopher L Brown; Yusuke Yamauchi; Ian E Cock
Journal:  J R Soc Interface       Date:  2020-06-24       Impact factor: 4.118

Review 2.  Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers.

Authors:  Fan Leng; Fang Liu; Yongtao Yang; Yu Wu; Weiqun Tian
Journal:  Nanomaterials (Basel)       Date:  2018-03-28       Impact factor: 5.076

3.  Bioguided Fractionation of Local Plants against Matrix Metalloproteinase9 and Its Cytotoxicity against Breast Cancer Cell Models: In Silico and In Vitro Study.

Authors:  Maywan Hariono; Rollando Rollando; Jasson Karamoy; Pandu Hariyono; M Atmono; Maria Djohan; Wiwy Wiwy; Rina Nuwarda; Christopher Kurniawan; Nurul Salin; Habibah Wahab
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

4.  Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer.

Authors:  Prangwan Pateetin; Gyorgy Hutvagner; Sarah Bajan; Matthew P Padula; Eileen M McGowan; Viroj Boonyaratanakornkit
Journal:  Sci Data       Date:  2021-04-12       Impact factor: 6.444

5.  Evaluation of Indonesian mangrove Xylocarpus granatum leaves ethyl acetate extract as potential anticancer drug.

Authors:  Jason Darmadi; Razethy Rahayu Batubara; Sandiego Himawan; Norma Nur Azizah; Hilyatushalihah Kholis Audah; Ade Arsianti; Evi Kurniawaty; Intan Safinar Ismail; Irmanida Batubara; Kholis Abdurachim Audah
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

6.  Paeoniflorin Enhances the Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen through Promoting Sirtuin 4.

Authors:  Pei Zhang; Nan Wu; Zhi-Jun Song; Zheng-Fu Tai
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-15       Impact factor: 2.629

7.  Non-SMC condensin I complex subunit H promotes the malignant progression and cisplatin resistance of breast cancer MCF-7 cells.

Authors:  Linhong Liao; Hui Cheng; Shusong Liu
Journal:  Oncol Lett       Date:  2022-07-19       Impact factor: 3.111

8.  CCM signaling complex (CSC) couples both classic and non-classic Progesterone receptor signaling.

Authors:  Johnathan Abou-Fadel; Xiaoting Jiang; Brian Grajeda; Akhil Padarti; Cameron C Ellis; Esmeralda Flores; Alyssa-Marie D Cailing-De La O; Jun Zhang
Journal:  Cell Commun Signal       Date:  2022-08-15       Impact factor: 7.525

Review 9.  In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy.

Authors:  Gary J Cheng; Euphemia Y Leung; Dean C Singleton
Journal:  Explor Target Antitumor Ther       Date:  2022-06-01

10.  Bio-selective hormonal breast cancer cytotoxic and antioxidant potencies of Melia azedarach L. wild type leaves.

Authors:  Martha Ervina; Hadi Poerwono; Retno Widyowati; Katsuyoshi Matsunami
Journal:  Biotechnol Rep (Amst)       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.